Inspire Medical Systems Swings to Q3 Earnings, Revenue Surge; 2024 Guidance Lifted

MT Newswires Live11-05

Inspire Medical Systems (INSP) reported Q3 earnings late Monday of $0.60 per diluted share, swinging from a net loss of $0.29 a year earlier.

Analysts polled by Capital IQ expected $0.06.

Revenue for the quarter that ended Sept. 30 was $203.2 million, up from $153.3 million a year earlier.

Analysts surveyed by Capital IQ expected $197.6 million.

The company now expects full-year 2024 earnings of between $1.20 and $1.40 per diluted share, compared with its prior forecasts of $0.60 to $0.80. Analysts surveyed by Capital IQ expect $0.75.

The company now expects revenue for the full year of between $793 million and $798 million, versus its previous projections of $788 million to $798 million. Analysts polled by Capital IQ expect $795.1 million.

Shares of Inspire Medical Systems were up over 2% in after-hours activity.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment